NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

Baroda BNP Paribas Health and Wellness Fund -Growth for NRI [9.06]

Min Investment

1,000

Fund Size

564.85 Cr

Expense Ratio

2.3%

Exit Load

%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

9.06

-0.43%

NAV as on 01 Apr 26, 12:00 AM

risk

sector specific pharma

equity

NAV as on 01 Apr 26, 12:00 AM

risk

sector specific pharma

equity

0.00%p.a.

Last 1Y

0.00%p.a.

Last 3Y

0.00%p.a.

Last 5Y

-9.36%p.a.

Since Inception

About Baroda BNP Paribas Health and Wellness Fund -Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the Baroda BNP Paribas Health and Wellness Fund -Growth scheme from Baroda BNP Paribas Asset Management India Pvt. Ltd. It is a Sector Specific - Pharma mutual fund scheme that predominantly invests in Sector Specific - Pharma stocks of companies. Launched on Jun 2025, Baroda BNP Paribas Health and Wellness Fund -Growth is Sector Specific - Pharma fund of its category with 564.85 Cr fund under management as on Apr 2026. The expense ratio of this fund is less than that of most other Fund category Sector Specific - Pharma funds.

  • Baroda BNP Paribas Health and Wellness Fund -Growth delivered 0.0% annual returns during the last year. It has delivered -9.4% average annual returns since the fund was launched.
  • Baroda BNP Paribas Health and Wellness Fund -Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in equity

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized

Top 10 Holdings

Abbott India Ltd

4.60%

Ajanta Pharma Ltd

2.25%

Apollo Hospitals Enterprise Ltd

4.15%

Astrazeneca Pharma India Ltd

4.07%

Sanofi India Ltd

0.40%

Cipla Ltd

2.15%

Divi's Laboratories Ltd

1.92%

Fortis Healthcare Ltd

4.59%

JB Chemicals & Pharmaceuticals Ltd

3.64%

Sun Pharmaceutical Industries Ltd

9.23%

Fund Managers

  1. Sanjay Chawla (Jun 2025 - Present)

Key Information

View Scheme Document

Baroda BNP Paribas Health and Wellness Fund -Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on Baroda BNP Paribas Health and Wellness Fund -Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in Baroda BNP Paribas Health and Wellness Fund -Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Baroda BNP Paribas Health and Wellness Fund -Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions